OGN
Organon & Co. Healthcare - Drug Manufacturers - General Investor Relations →
Organon & Co. (OGN) closed at $13.29 as of 2026-05-01, trading 16.2% below its 200-week moving average of $15.86. This places OGN in the extreme value zone. The stock moved further from the line this week, up from -29.3% last week. The 14-week RSI sits at 64, indicating neutral momentum.
A big jump in activity this week — 5.3x the usual volume, and the price went up. Significantly more people than usual decided to buy. This kind of surge, especially on a stock already below its 200-week average, can be an early sign that sentiment is shifting.
Over the past 211 weeks of data, OGN has crossed below its 200-week moving average 3 times. On average, these episodes lasted 67 weeks. The average one-year return after crossing below was -29.0%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $3.5 billion, OGN is a mid-cap stock. The stock trades at 4.6x book value.
Share count has increased 2.3% over three years, indicating dilution.
Over the past 4.1 years, a hypothetical investment of $100 in OGN would have grown to $49, compared to $184 for the S&P 500. OGN has returned -16.0% annualized vs 16.2% for the index, underperforming the broader market over this period.
In the past 12 months, corporate insiders have made 7 open-market purchases totaling $1,153,381. Multiple insiders purchased within a 30-day window — a cluster buy pattern that historically signals management confidence in the company's prospects. Notably, these purchases occurred while OGN is trading below its 200-week moving average — insiders are buying when the market is most pessimistic.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: OGN vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After OGN Crosses Below the Line?
Across 3 historical episodes, buying OGN when it crossed below its 200-week moving average produced an average return of -30.3% after 12 months (median -29.0%), compared to +12.3% for the S&P 500 over the same periods. After 24 months, the average return was -33.3% vs +38.7% for the index.
Each line shows $100 invested at the moment OGN crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
OGN has crossed below its 200-week MA 3 times with an average 1-year return of +-29.0% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Apr 2022 | May 2022 | 2 | 1.1% | -22.3% | -50.8% |
| Jul 2022 | Jan 2023 | 27 | 27.0% | -35.8% | -51.9% |
| Jan 2023 | Ongoing | 171+ | 64.3% | Ongoing | -48.5% |
| Average | 67 | — | +-29.0% | — |
Frequently Asked Questions
Is OGN below its 200-week moving average?
Yes. As of 2026-05-01, Organon & Co. (OGN) is trading 16.2% below its 200-week moving average of $15.86. The current price is $13.29.
What is OGN's 200-week moving average price?
Organon & Co.'s 200-week moving average is $15.86 as of 2026-05-01. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when OGN drops below its 200-week moving average?
OGN has crossed below its 200-week moving average 3 times in our data. The average one-year return after these crossings was -29.0%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 67 weeks on average.
Is OGN a good value right now?
Here's what our data says about OGN as of 2026-05-01: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 64. Price-to-book is 4.6x. This is not a buy or sell recommendation — always do your own research.
How does OGN compare to the S&P 500?
Over the past 4.1 years, $100 invested in OGN would have grown to $49, compared to $184 for the S&P 500. That's -16.0% annualized vs 16.2% for the index. OGN has underperformed the broader market over this period.
Does OGN pay a dividend?
Yes. Organon & Co. currently pays a dividend yield of 60.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-05-01